Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.42B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.66B |
| 3 |
CRH
CRH
|
+$671M |
| 4 |
Apple
AAPL
|
+$505M |
| 5 |
Microsoft
MSFT
|
+$501M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.55B |
| 2 |
Toronto Dominion Bank
TD
|
+$581M |
| 3 |
Bank of Montreal
BMO
|
+$498M |
| 4 |
Canadian Natural Resources
CNQ
|
+$492M |
| 5 |
Starbucks
SBUX
|
+$487M |
Sector Composition
| 1 | Technology | 19.06% |
| 2 | Financials | 18.37% |
| 3 | Industrials | 7.87% |
| 4 | Healthcare | 7.61% |
| 5 | Consumer Discretionary | 6.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5251
Y-mAbs Therapeutics
YMAB
$390M
| $42K | ﹤0.01% |
3,459
+2,622
| +313% | +$31.8K |
|
5252
AdvisorShares Pure Cannabis ETF
YOLO
$40M
| $42K | ﹤0.01% |
12,606
-32
| -0.3% | -$107 |
|
|
SAVE
5253
DELISTED
Spirit Airlines, Inc.
SAVE
| $42K | ﹤0.01% |
11,422
-15,468
| -58% | -$56.9K |
|
5254
Advantage Solutions
ADV
$619M
| $41K | ﹤0.01% |
13,002
+4,924
| +61% | +$15.5K |
|
5255
CureVac
CVAC
$1.2B
| $41K | ﹤0.01% |
11,968
+4,035
| +51% | +$13.8K |
|
5256
ARS Pharmaceuticals
SPRY
$991M
| $41K | ﹤0.01% |
4,829
+2,640
| +121% | +$22.4K |
|
|
URG
5257
Ur-Energy
URG
$533M
| $41K | ﹤0.01% |
29,665
+13,588
| +85% | +$18.8K |
|
5258
Albemarle Corp Depositary Shares
ALB.PRA
$1.67B
| – | – |
0
| – | – |
|
5259
Adaptive Biotechnologies
ADPT
$1.92B
| $40K | ﹤0.01% |
11,244
+7,402
| +193% | +$26.3K |
|
|
AGEN
5260
Agenus
AGEN
$143M
| $40K | ﹤0.01% |
2,385
+1,873
| +366% | +$31.4K |
|
5261
Blue Foundry Bancorp
BLFY
$198M
| $40K | ﹤0.01% |
4,427
+1,503
| +51% | +$13.6K |
|
5262
Caesarstone
CSTE
$48.4M
| $40K | ﹤0.01% |
7,946
+4,755
| +149% | +$23.9K |
|
5263
Viant Technology
DSP
$158M
| $40K | ﹤0.01% |
4,095
+676
| +20% | +$6.6K |
|
5264
Amplify International Enhanced Dividend Income ETF
IDVO
$397M
| $40K | ﹤0.01% |
1,332
+661
| +99% | +$19.9K |
|
5265
MediaAlpha
MAX
$688M
| $40K | ﹤0.01% |
2,986
+1,921
| +180% | +$25.7K |
|
5266
Montauk Renewables
MNTK
$287M
| $40K | ﹤0.01% |
6,999
+5,506
| +369% | +$31.5K |
|
5267
OmniAb
OABI
$236M
| $40K | ﹤0.01% |
10,449
+6,483
| +163% | +$24.8K |
|
5268
Ocugen
OCGN
$334M
| $40K | ﹤0.01% |
25,735
+17,401
| +209% | +$27K |
|
5269
Rayonier Advanced Materials
RYAM
$421M
| $40K | ﹤0.01% |
7,358
+4,593
| +166% | +$25K |
|
5270
Spire Global
SPIR
$307M
| $40K | ﹤0.01% |
3,672
+2,598
| +242% | +$28.3K |
|
5271
SoundThinking
SSTI
$160M
| $40K | ﹤0.01% |
3,285
+590
| +22% | +$7.18K |
|
|
AEF
5272
abrdn Emerging Markets Equity Income Fund
AEF
$261M
| $39K | ﹤0.01% |
7,464
+14
| +0.2% | +$73 |
|
5273
Astria Therapeutics
ATXS
$419M
| $39K | ﹤0.01% |
4,236
+3,120
| +280% | +$28.7K |
|
5274
Aura Biosciences
AURA
$384M
| $39K | ﹤0.01% |
5,216
+3,562
| +215% | +$26.6K |
|
5275
FT Vest US Equity Moderate Buffer ETF July
GJUL
$611M
| $39K | ﹤0.01% |
+1,114
| New | +$39K |
|